Minerva Surgical Inc (NASDAQ:UTRS) saw an upside of 55.22% to close Tuesday at $0.28 after adding $0.1 on the day. The 5-day average trading volume is 1,038,020 shares of the company’s common stock. It has gained $0.3080 in the past week and touched a new high 4 times within the past 5 days. An average of 330,870 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 308,978.
UTRS’s 1-month performance is 35.82% or $0.0745 on its low of $0.1700 reached on 09/20/23. The company’s shares have touched a 52-week low of $0.15 and high of $0.90, with the stock’s rally to the 52-week high happening on 05/24/23. YTD, UTRS has achieved 26.45% or $0.0591 and has reached a new high 5 times. However, the current price is down -68.59% from the 52-week high price.
Valuation Metrics
UTRS stock has a beta of 1.33. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.96 while the price-to-book (PB) in the most recent quarter is 1.89.
Minerva Surgical Inc’s quick ratio for the period ended June 29 was 1.56, with the current ratio over the same period at 2.55. As well, the company’s long term debt to equity for the quarter ending June 29 was 1.30, while the total debt to equity was 1.64.. In terms of profitability, the gross margin trailing 12 months is 54.67%. The trailing 12-month EBITDA margin is -56.79% while for the period ending June 29, Minerva Surgical Inc’s operating margin was -73.91%. The firm’s gross profit as reported stood at $27.24 million against revenue of $50.29 million.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 35.37% to -$8.68 million, while revenue of -$11.34 million was -30.65% off the previous quarter. Analysts expected UTRS to announce -$0.09 per share in earnings in its latest quarter, but it posted -$0.05, representing a 44.40% surprise. EBITDA for the quarter stood at more than -$5.61 million. UTRS stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 52.72 million, with total debt at $43.62 million. Shareholders hold equity totaling $177.56 million.
Let’s look briefly at Minerva Surgical Inc (UTRS) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 26 September was 77.12% to suggest the stock is trending Overbought, with historical volatility in this time period at 228.32%.
The stock’s 5-day moving average is $0.2099, reflecting a +48.68% or $0.0925 change from its current price. UTRS is currently trading +36.01% above its 20-day SMA, +25.56% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +12.55% and SMA200 by+58.98%.
Stochastic %K and %D was 51.34% and 43.47% and the average true range (ATR) pointed at 0.0304. The RSI (14) points at 70.59%, while the 14-day stochastic is at 81.52% with the period’s ATR at 0.0259. The stock’s 9-day MACD Oscillator is pointing at 0.0163 and 0.0173 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Minerva Surgical Inc (NASDAQ: UTRS), UBS launched coverage with a Buy rating. Analysts offering their rating for UTRS stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate UTRS as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 1 have offered a “buy” rating.
What is UTRS’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $1.00 and a high of $1.00, with their median price target at $1.00. Looking at these predictions, the average price target given by analysts is for Minerva Surgical Inc (UTRS) stock is $1.00.
